Related Experiment Video
Updated: Oct 6, 2025

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
SRDFM: Siamese Response Deep Factorization Machine to improve anti-cancer drug recommendation
Ran Su1, YiXuan Huang2, De-Gan Zhang3,4
1The University of New South Wales, Australia.
Abstract:
Predicting the response of cancer patients to a particular treatment is a major goal of modern oncology and an important step toward personalized treatment. In the practical clinics, the clinicians prefer to obtain the most-suited drugs for a particular patient instead of knowing the exact values of drug sensitivity. Instead of predicting the exact value of drug response, we proposed a deep learning-based method, named Siamese Response Deep Factorization Machines (SRDFM) Network, for personalized anti-cancer drug recommendation, which directly ranks the drugs and provides the most effective drugs. A Siamese network (SN), a type of deep learning network that is composed of identical subnetworks that share the same architecture, parameters and weights, was used to measure the relative position (RP) between drugs for each cell line. Through minimizing the difference between the real RP and the predicted RP, an optimal SN model was established to provide the rank for all the candidate drugs. Specifically, the subnetwork in each side of the SN consists of a feature generation level and a predictor construction level. On the feature generation level, both drug property and gene expression, were adopted to build a concatenated feature vector, which even enables the recommendation for newly designed drugs with only chemical property known. Particularly, we developed a response unit here to generate weighted genetic feature vector to simulate the biological interaction mechanism between a specific drug and the genes. For the predictor construction level, we built this level integrating a factorization machine (FM) component with a deep neural network component. The FM can well handle the discrete chemical information and both low-order and high-order feature interactions could be sufficiently learned. Impressively, the SRDFM works well on both single-drug recommendation and synergic drug combination. Experiment result on both single-drug and synergetic drug data sets have shown the efficiency of the SRDFM. The Python implementation for the proposed SRDFM is available at at https://github.com/RanSuLab/SRDFM Contact: ran.su@tju.edu.cn, gbx@mju.edu.cn and weileyi@sdu.edu.cn.
Insights
We developed a deep learning model called Siamese Response Deep Factorization Machines (SRDFM) Network for personalized anti-cancer drug recommendation. This method ranks drugs to identify the most effective treatments for individual cancer patients, improving personalized oncology.
Area of Science:
- Oncology
- Bioinformatics
- Artificial Intelligence
Background:
- Personalized cancer treatment requires predicting patient response to therapies.
- Clinicians need effective drug recommendations rather than precise sensitivity values.
- Existing methods may not adequately handle complex drug-gene interactions or novel drug properties.
Purpose of the Study:
- To develop a deep learning-based method for personalized anti-cancer drug recommendation.
- To directly rank drugs for identifying the most effective treatments for individual cancer patients.
- To enable drug recommendations even for new drugs with limited known properties.
Main Methods:
- Proposed the Siamese Response Deep Factorization Machines (SRDFM) Network, a deep learning model.
- Utilized a Siamese network (SN) to measure the relative position (RP) between drugs for cell lines.
- Integrated drug properties and gene expression data, incorporating a response unit for weighted genetic features.
- Combined Factorization Machines (FM) with deep neural networks for predictor construction.
Main Results:
- The SRDFM network effectively ranks anti-cancer drugs for personalized recommendation.
- The model demonstrates efficiency in both single-drug and drug combination recommendations.
- The approach successfully simulates biological interaction mechanisms between drugs and genes.
- The method accommodates new drugs by utilizing chemical properties.
Conclusions:
- The SRDFM Network provides a powerful tool for personalized anti-cancer drug recommendation.
- This deep learning approach enhances the identification of effective cancer treatments.
- The SRDFM Network shows promise for advancing precision oncology and drug discovery.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

